Lymphoma Treatment in the US: Options, Care Teams and Treatment Questions

Receiving a diagnosis of lymphoma — whether Hodgkin or non-Hodgkin — marks the beginning of a journey that involves making important decisions alongside medical professionals. Knowing what to expect, what questions to ask, and what resources are available can help patients and their families navigate that path with greater confidence.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

What Are the Main Lymphoma Treatment Options?

Lymphoma treatment options vary significantly depending on the type and stage of lymphoma, the patient’s overall health, and other individual factors. The most commonly used approaches include chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Chemotherapy remains a cornerstone of treatment for many lymphoma types, often delivered in combination regimens. Radiation therapy may be used alongside chemotherapy or as a standalone approach in localized cases. Immunotherapy — which helps the immune system recognize and attack cancer cells — has grown considerably in use over recent years and plays a central role in many current treatment plans.

How Are New Lymphoma Treatments Changing Care?

The field of lymphoma therapy has evolved rapidly. New lymphoma treatments such as CAR-T cell therapy (chimeric antigen receptor T-cell therapy) have offered renewed hope to patients with relapsed or refractory lymphoma. This approach involves modifying a patient’s own immune cells to better target cancer, and it has demonstrated meaningful results in clinical settings. Bispecific antibodies are another emerging category, designed to engage immune cells and tumor cells simultaneously. These advances reflect a broader shift toward more personalized, precision-based treatment strategies in oncology.

Understanding Lymphoma Therapy and Your Care Team

Effective lymphoma therapy is rarely delivered by a single specialist. In the US, patients are typically supported by a multidisciplinary team that may include a hematologist-oncologist, radiation oncologist, pathologist, pharmacist, social worker, and oncology nurse. Understanding the role of each team member — and feeling empowered to ask questions — is a key part of navigating treatment. Patients are encouraged to ask about the goals of each phase of treatment, potential side effects, the expected timeline, and what monitoring will look like throughout the process.

What Lymphoma Medications Are Commonly Used?

Lymphoma medications span several categories. Rituximab, a monoclonal antibody, is widely used in the treatment of B-cell non-Hodgkin lymphomas and is often combined with chemotherapy regimens. Brentuximab vedotin is an antibody-drug conjugate used in certain types of Hodgkin lymphoma and some T-cell lymphomas. BTK inhibitors like ibrutinib are used in specific subtypes of non-Hodgkin lymphoma. Corticosteroids are frequently included in multi-drug regimens. The selection of medications depends heavily on the precise lymphoma subtype, prior treatments, and individual patient considerations, and is always determined by the treating oncologist.

Are Lymphoma Clinical Trials an Option Worth Exploring?

Lymphoma clinical trials play a vital role in expanding what is possible in treatment. For patients who have not responded to standard therapies, or those who want access to emerging approaches, clinical trials can be a meaningful avenue to explore. Trials are conducted at academic medical centers, cancer centers, and community hospitals throughout the United States. ClinicalTrials.gov, maintained by the National Institutes of Health, is a publicly accessible database where patients and caregivers can search for studies by lymphoma type, location, and eligibility criteria. Discussing clinical trial eligibility with an oncologist is a reasonable step during any stage of treatment planning.

Questions to Ask Your Care Team About Lymphoma

Having a prepared list of questions before appointments can make a real difference. Useful questions include: What type and stage of lymphoma has been diagnosed? What are the recommended treatment options and why? What are the expected side effects, both short-term and long-term? How will treatment affect daily life? Are there clinical trials I may be eligible for? What does follow-up care look like after treatment ends? Keeping a written record of answers — or bringing a trusted support person to appointments — can help ensure that important information is retained and acted upon.

Lymphoma treatment in the United States continues to advance, with a growing range of therapies and a stronger emphasis on individualized care. Whether navigating a new diagnosis or exploring options after prior treatment, staying informed and maintaining open communication with a qualified medical team remains central to making well-grounded decisions about care.